BDBM714772 4-((5-(2-chloro-4-fluoro-3- hydroxyphenyl)-1,3,4-thiadiazol-2- yl)methyl)-6-(2,4-difluorobenzyl)- 4,6-diazaspiro[2.4]heptane-5,7- dione::US20250026745, Compound I-33

SMILES O=C1N(Cc2ccc(F)cc2F)C(=O)C2(CC2)N1Cc1nnc(-c2ccc(F)c(O)c2Cl)s1

InChI Key InChIKey=BXWMUXZCFSVUAZ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 714772   

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Bluejay Therapeutics

US Patent
LigandPNGBDBM714772(4-((5-(2-chloro-4-fluoro-3- hydroxyphenyl)-1,3,4-t...)
Affinity DataIC50: 8.83nMAssay Description:More specifically, recombinant 17β-HSD13 protein was assayed in a buffer containing 200 mM Tris pH 7.5, 0.01% Triton X-100, and 0.02% BSA into a 384-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent